Literature DB >> 15726452

Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs.

S Jähnichen1, E Glusa, H H Pertz.   

Abstract

This study characterizes the relaxant response to 5-hydroxytryptamine (5-HT) in prostaglandin F(2alpha) (PGF(2alpha))-precontracted pulmonary arteries of weaned pigs. In arterial rings with intact endothelium, the relaxation to 5-HT was biphasic. The high affinity component of relaxation to 5-HT (0.1-10 nM) was abolished by mechanical removal of the endothelium or after the addition of L: -NAME (200 microM), and was inhibited by the 5-HT(2B/2C) receptor antagonist SB 206553 (1 microM), but not the 5-HT(2C) receptor antagonist SB 242084 (0.1 microM). Endothelium-intact arteries were also relaxed by the selective 5-HT(2B) receptor agonist BW 723C86 (pD(2) 7.7). The relaxant response to BW 723C86 was inhibited by 1 microM SB 206553 (pK(B) 6.8). The low affinity component of relaxation to 5-HT (>/=30 nM) remained unaffected after mechanical removal of the endothelium or the addition of L: -NAME. In endothelium-denuded arterial rings, 5-HT, 5-carboxamidotryptamine (5-CT), 5-methoxytryptamine (5-MeOT), and frovatriptan produced monophasic relaxations with pD(2) values of 6.5, 7.5, 5.9, and 4.7 respectively. Relaxant responses to the agonists were antagonized by the selective 5-HT(7) receptor antagonist SB 269970 (pK(B) 8.2-8.9). The relaxant response to the potent 5-HT(7) receptor agonist 5-CT was also antagonized by methiothepin (pK(B) 9.6), pimozide (pK(B) 8.2), mesulergine (pK(B) 7.7), methysergide (pK(B) 7.4), clozapine (pK(B) 7.6), and spiperone (pK(B) 7.4). The estimated pK(B) values argue in favor of an involvement of 5-HT(7) receptors in the direct vasorelaxant action of 5-HT in the pulmonary arteries of weaned pigs. The relaxant response to 5-CT was associated with an increase in cAMP that was surmountably antagonized by SB 269970 (pK(B) 8.6). The present in vitro bioassay can be used to characterize new drugs with potential agonist or antagonist properties at functional 5-HT(7) receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15726452     DOI: 10.1007/s00210-004-1006-6

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

1.  A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).

Authors:  P J Lovell; S M Bromidge; S Dabbs; D M Duckworth; I T Forbes; A J Jennings; F D King; D N Middlemiss; S K Rahman; D V Saunders; L L Collin; J J Hagan; G J Riley; D R Thomas
Journal:  J Med Chem       Date:  2000-02-10       Impact factor: 7.446

2.  6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist.

Authors:  S M Bromidge; M Duckworth; I T Forbes; P Ham; F D King; K M Thewlis; F E Blaney; C B Naylor; T P Blackburn; G A Kennett; M D Wood; S E Clarke
Journal:  J Med Chem       Date:  1997-10-24       Impact factor: 7.446

Review 3.  The 5-HT7 receptor: orphan found.

Authors:  R M Eglen; J R Jasper; D J Chang; G R Martin
Journal:  Trends Pharmacol Sci       Date:  1997-04       Impact factor: 14.819

Review 4.  Molecular, pharmacological and functional diversity of 5-HT receptors.

Authors:  Daniel Hoyer; Jason P Hannon; Graeme R Martin
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

5.  Involvement of 5-hydroxytryptamine7 receptors in inhibition of porcine myometrial contractility by 5-hydroxytryptamine.

Authors:  T Kitazawa; O Kubo; M Satoh; T Taneike
Journal:  Br J Pharmacol       Date:  1998-01       Impact factor: 8.739

Review 6.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology.

Authors:  D H Jenkinson; E A Barnard; D Hoyer; P P Humphrey; P Leff; N P Shankley
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

7.  Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.

Authors:  R Kohen; M A Metcalf; N Khan; T Druck; K Huebner; J E Lachowicz; H Y Meltzer; D R Sibley; B L Roth; M W Hamblin
Journal:  J Neurochem       Date:  1996-01       Impact factor: 5.372

Review 8.  Partial agonists, full agonists, antagonists: dilemmas of definition.

Authors:  D Hoyer; H W Boddeke
Journal:  Trends Pharmacol Sci       Date:  1993-07       Impact factor: 14.819

9.  5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor.

Authors:  I Morecroft; R P Heeley; H M Prentice; A Kirk; M R MacLean
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

10.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more
  14 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 2.  Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives.

Authors:  Anne Matthys; Guy Haegeman; Kathleen Van Craenenbroeck; Peter Vanhoenacker
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

Review 3.  5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.

Authors:  Stephanie W Watts; Robert Patrick Davis
Journal:  Cardiovasc Ther       Date:  2011-02       Impact factor: 3.023

4.  5-HT causes splanchnic venodilation.

Authors:  Bridget M Seitz; Hakan S Orer; Teresa Krieger-Burke; Emma S Darios; Janice M Thompson; Gregory D Fink; Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

5.  Serotonin receptors in rat jugular vein: presence and involvement in the contraction.

Authors:  A Elizabeth Linder; Geri L Gaskell; Theodora Szasz; Janice M Thompson; Stephanie W Watts
Journal:  J Pharmacol Exp Ther       Date:  2010-04-08       Impact factor: 4.030

6.  Long-term maternal hypoxia: the role of extracellular Ca2+ entry during serotonin-mediated contractility in fetal ovine pulmonary arteries.

Authors:  Ravi Goyal; Demosthenes G Papamatheakis; Matthew Loftin; Kurt Vrancken; Antoinette S Dawson; Noah J Osman; Arlin B Blood; William J Pearce; Lawrence D Longo; Sean M Wilson
Journal:  Reprod Sci       Date:  2011-10       Impact factor: 3.060

7.  Potassium channels are involved in testosterone-induced vasorelaxation of human umbilical artery.

Authors:  Elisa Cairrão; Ezequiel Alvarez; António José Santos-Silva; Ignacio Verde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-20       Impact factor: 3.000

Review 8.  Triptans in pregnancy.

Authors:  Offie P Soldin; Julia Dahlin; Daniel M O'Mara
Journal:  Ther Drug Monit       Date:  2008-02       Impact factor: 3.681

9.  Expression and function of 5-HT7 receptors in smooth muscle preparations from equine duodenum, ileum, and pelvic flexure.

Authors:  Andrea S Prause; Michael H Stoffel; Christopher J Portier; Meike Mevissen
Journal:  Res Vet Sci       Date:  2009-04-11       Impact factor: 2.534

10.  Vascular smooth muscle modulates endothelial control of vasoreactivity via reactive oxygen species production through myoendothelial communications.

Authors:  Marie Billaud; Roger Marthan; Jean-Pierre Savineau; Christelle Guibert
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.